BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Drug Development

  Chimerix, Inc.'s Broad-Spectrum Antiviral CMX001 Shown in Animal Model to be a Potent Inhibitor of Herpes Simplex Viruses

  November 22, 2010

   · 

  6 min read
• Biotech Beach

  iTech Medical Announces CEO Wayne Cockburn’s Exclusive Interview

  November 22, 2010

   · 

  1 min read
• Lone Star Bio

  Caris Life Sciences Expands Molecular R&D Capabilities Globally to Speed Commercialization Efforts

  November 22, 2010

   · 

  1 min read
• Genetown

  Advanced Cell Technology Receives FDA Clearance For the First Clinical Trial Using Embryonic Stem Cells to Treat Macular Degeneration

  November 22, 2010

   · 

  1 min read
• BioForest

  OncoGenex Pharmaceuticals Inc. to Present at the Piper Jaffray 22nd Annual “Unplugged” Health Care Conference

  November 22, 2010

   · 

  1 min read
• Alexion Pharmaceuticals Inc. Phase 2 Study of Eculizumab in Patients with aHUS Resistant to Plasma Therapy Met Primary and Secondary Endpoints with High Statistical and Clinical Significance

  November 22, 2010

   · 

  13 min read
• Biotech Bay

  Abaxis, Inc. to Present at Piper Jaffray 22nd Annual Health Care Conference

  November 22, 2010

   · 

  1 min read
• Drug Development

  Regeneration Technologies Inc. Schedules November 22, 2010 Teleconference and Webcast to Discuss Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration

  November 22, 2010

   · 

  1 min read
• Drug Development

  Reata Pharmaceuticals, Inc. and Abbott Laboratories Announce Positive Phase 2b Study Results for Bardoxolone Methyl

  November 22, 2010

   · 

  4 min read
• Drug Development

  Cell Therapeutics, Inc.: Paclitaxel Poliglumex (OPAXIO®) Combined with Temozolomide and Radiotherapy Demonstrates High Response Rates with Encouraging Progression Free Survival in Malignant Brain Cancer

  November 22, 2010

   · 

  5 min read